PTAB statistics

PTAB Trial Statistics as of September 30, 2016

As of September 30, 2016, USPTO records show 5,670 AIA trial petitions filed since September 16, 2012 (5,143 IPR, 476 CBM, 37 PGR, 14 derivation). The Board had instituted trial on 2,796 petitions and denied 1,870 (59.9% instituted) and had issued 1,406 final written decisions. In fiscal year 2016 to that date, 1,689 petitions were filed.

Key Facts

As of
September 30, 2016
Fiscal year
FY2016
Petitions filed (cumulative)
5,670
Institution rate (cumulative)
59.9%
Petitions filed (FY2016 to date)
1,689
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of September 30, 2016
  2. Fiscal Year 2016 to Date
  3. Change Since July 31, 2016
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of September 30, 2016, which falls in fiscal year 2016 (October 1, 2015 to September 30, 2016). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2016 statistics page.

Cumulative Figures as of September 30, 2016

Events from September 16, 2012 to September 30, 2016, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed5,14337476145,670
Institution decisions: instituted2,5191426302,796
Institution decisions: denied1,690916831,870
Institution rate (by petition)59.8%60.9%61.0%0.0%59.9%
Final written decisions1,251315201,406
Terminations without a final written decisionCount
Settlements699
Adverse judgment0
Dismissed0
Other terminations101

Fiscal Year 2016 to Date

Events from October 1, 2015 to September 30, 2016:

MeasureIPRPGRCBMDERTotal
Petitions filed1,565249461,689
Institution decisions: instituted88011520943
Institution decisions: denied6487580713
Institution rate (by petition)57.6%61.1%47.3%—56.9%
Final written decisions6433700716
Terminations without a final written decisionCount
Settlements275
Adverse judgment0
Dismissed0
Other terminations60

Change Since July 31, 2016

Between the previous dated page (July 31, 2016) and September 30, 2016, 299 petitions were filed, 154 trials were instituted, 86 petitions were denied institution and 127 final written decisions issued. The cumulative institution rate moved from 59.7% to 59.9%.

Trial Types Covered

5,143 of the 5,670 petitions (90.7%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (476), post-grant review under chapter 32 (37) and derivation proceedings (14). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before September 30, 2016: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of September 30, 2016?

USPTO records show 5,670 petitions filed from September 16, 2012 to September 30, 2016: 5,143 IPR, 476 CBM, 37 PGR and 14 derivation.

What was the PTAB institution rate as of September 30, 2016?

Cumulatively, 59.9% by petition: 2,796 instituted and 1,870 denied. In FY2016 to that date the rate was 56.9%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.